Associations of IL6 rs1800795, BLK rs13277113, TIMP3 rs9621532, IL1RL1 rs1041973 and IL1RAP rs4624606 single gene polymorphisms with laryngeal squamous cell carcinoma.


Journal

Gene
ISSN: 1879-0038
Titre abrégé: Gene
Pays: Netherlands
ID NLM: 7706761

Informations de publication

Date de publication:
15 Jul 2020
Historique:
received: 01 03 2020
revised: 06 04 2020
accepted: 18 04 2020
pubmed: 25 4 2020
medline: 19 5 2020
entrez: 25 4 2020
Statut: ppublish

Résumé

Survival rate of laryngeal squamous cell carcinoma (LSCC) patients is not improving. To understand more complete biology of LSCC, studies focused on identification of new specific and prognostic markers are performed. The aim of current study was to evaluate the impact of five different single nucleotide polymorphisms (SNP) (IL6 rs1800795, BLK rs13277113, TIMP3 rs9621532, IL1RL1 rs1041973 and IL1RAP rs4624606) on LSCC development. A total of 891 subjects (353 histologically verified LSCC patients and 538 healthy controls) were involved in this study. The genotyping was carried out using the real-time-PCR. Statistical analysis revealed statistically significant associations between TIMP3 rs96215332 variants and LSCC in the codominant (OR = 0.600; 95% CI: 0.390-0.922; p = 0.020), overdominant (OR = 0.599; 95% CI: 0.390-0.922; p = 0.020) and additive (OR = 0.675; 95% CI: 0.459-0.991; p = 0.045) models. Also, significant variants of IL1RAP rs4624606 were determined in the codominant (OR = 1.372; 95% CI: 1.031-1.827; p = 0.030), overdominant (OR = 1.353; 95% CI: 1.018-1.798; p = 0.037) and additive (OR = 1.337; 95% CI: 1.038-1.724; p = 0.025) models. Results of the current study indicate significant associations between TIMP3 rs9621532 and IL1RAP rs4624606 gene polymorphisms and LSCC development.

Identifiants

pubmed: 32330537
pii: S0378-1119(20)30369-3
doi: 10.1016/j.gene.2020.144700
pii:
doi:

Substances chimiques

IL1RAP protein, human 0
IL1RL1 protein, human 0
Interleukin-1 Receptor Accessory Protein 0
Interleukin-1 Receptor-Like 1 Protein 0
Interleukin-6 0
TIMP3 protein, human 0
Tissue Inhibitor of Metalloproteinase-3 0
BLK protein, human EC 2.7.10.2
src-Family Kinases EC 2.7.10.2

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

144700

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Agne Pasvenskaite (A)

Department of Otorhinolaryngology, Lithuanian University of Health Sciences, Kaunas, Lithuania. Electronic address: agne.pasvenskaite@lsmuni.lt.

Alvita Vilkeviciute (A)

Neuroscience Institute, Lithuanian University of Health Sciences, Kaunas, Lithuania, Lithuania.

Rasa Liutkeviciene (R)

Neuroscience Institute, Lithuanian University of Health Sciences, Kaunas, Lithuania, Lithuania.

Greta Gedvilaite (G)

Neuroscience Institute, Lithuanian University of Health Sciences, Kaunas, Lithuania, Lithuania.

Vykintas Liutkevicius (V)

Department of Otorhinolaryngology, Lithuanian University of Health Sciences, Kaunas, Lithuania.

Virgilijus Uloza (V)

Department of Otorhinolaryngology, Lithuanian University of Health Sciences, Kaunas, Lithuania.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH